Quality of Life After Bariatric Surgery

Major, Piotr; Matłok, Maciej; Pędziwiatr, Michał; Migaczewski, Marcin; Budzyński, Piotr; Stanek, Maciej; Kisielewski, Michał; Natkaniec, Michał; Budzyński, Andrzej

doi:10.1007/s11695-015-1601-2

Cited by 111 publications

(85 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In some articles authors present higher percent of EWL after LRYGB. Our observation revealed that the weight reduction after both procedures is similar (12). In our study percent of EBMIL after LSG, measured 6 months after surgery, was 59.90% (46.75-69.28%) and it was comparable to others authors (13,14).…”

Section: Discussionsupporting

confidence: 90%

Laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus type 2 patients—single center early experience

et al. 2016

Self Cite

View full text Add to dashboard Cite

Background: In recent years, laparoscopic sleeve gastrectomy (LSG) has become one of the most commonly used primary bariatric procedures for morbid obesity. While laparoscopic Roux-en-Y gastric bypass (LRYGB) has well documented positive clinical influence on type 2 diabetes, the role of LSG in diabetes treatment is debatable. The main aim of this study is to present our early experience in LSG as a method of bariatric treatment in patients with type 2 diabetes or abnormalities in glucose homeostasis.Methods: Prospectively collected data of patients operated for morbid obesity at the 2nd Department of Surgery. The study was designed to assess the influence of LSG on type 2 diabetes and glucose homeostasis.The primary endpoint was the diabetes type 2 remission. Secondary endpoint was the change of glucose metabolism parameters after LSG. Patients were assessed preoperatively and allocated to two groups: group 1-with any preoperative abnormalities in glucose homeostasis (prediabetes, diabetes) and group 2-with non-elevated fasting glucose level. During follow-up (6 months after surgery) all glucose homeostasis parameters were analyzed again. One hundred and thirty-six patients after LSG were enrolled in the study (90 females, 46 males; mean age 40.5±9.9 years). Preoperative abnormalities in glucose homeostasis were confirmed in 64 (47%) patients. Twenty (15%) patients in this group had diabetes. Results:We observed significant reduction of body mass index (BMI) after surgery. Mean percent of EBMIL for all groups after 6 months from surgery was 59.90% (46.75-69.28%). There were no full remissions after surgery in patients with preoperative diabetes. We found significant improvement in biochemical markers of glucose homeostasis. We observed significant reduction of HbA1c% after surgery in both groups. The level of postoperative HbA1c% was related to BMI loss after surgery.Conclusions: LSG leads to significant improvement in biochemical glucose homeostasis and can be considered as a method of treatment in morbidly obese patients with glucose metabolism abnormalities. LSG as a method of treatment for patients with clinical type 2 diabetes still needs some further observation.

show abstract

Section: Discussionsupporting

confidence: 90%

Laparoscopic sleeve gastrectomy for the treatment of diabetes mellitus type 2 patients—single center early experience

et al. 2016

Self Cite

View full text Add to dashboard Cite

show abstract

“…In the majority of patients, there is a reduction of antihypertensive and diabetic drug use in the post-operative period [13]. An increase in quality of life is also observed [14]. So, if the risk factors of ED are removed due to surgery, is there a chance to reduce the prevalence of ED in post-bariatric patients?…”

Section: Introductionmentioning

confidence: 99%

Cross-sectional study of male sexual function in bariatric patients

Janik¹,

Bielecka²,

Janik³

et al. 2016

wiitm

View full text Add to dashboard Cite

IntroductionObesity is associated with numerous comorbidities and affects various aspects of life, including sexual functioning. Bariatric surgery is an effective treatment for obese people. Male sexual function after bariatric surgery is not well known.AimTo compare male sexual function and sexual quality of life after surgical weight loss with controls seeking bariatric surgery.Material and methodsInternational Index of Erectile Function and Sexual Quality of Life-Male (SQoL-M) questionnaires were administered by e-mail to 152 men who had undergone weight-loss surgery. The control group consisted of 44 obese men who completed the questionnaires during their preoperative evaluation.ResultsFifty-six percent of men in the control group and 20% of men in the postoperative group reported erectile dysfunction (ED) (OR = 5.1; 95% CI: 1.6–16.0, p = 0.005). The median (Q1, Q3) total International Index of Erectile Function (IIEF) score did not show a significant difference between the control (62.0 (37.5, 66.5)) and postoperative groups (67.0 (57.0, 70.0)). However, median scores in domains of erectile function (EF), sexual desire (SD), and overall satisfaction (OS) were significantly higher in the postoperative group. The median SQoL-M was significantly higher (81.8 (51.5, 89.4) vs. 88.6 (84.8, 90.9); p < 0.05) in the postoperative group.ConclusionsA lower prevalence of erectile dysfunction and better sexual quality of life were observed in the patients after surgical weight loss. The improvement in male sexual function may be considered as an advantage of bariatric surgery.

show abstract

“…weight loss, bariatric surgery induces a gain in life expectancy [3], a reduction in the risk of cancer [4], an improvement in quality of life (QOL) [5] and depression [6], and an increase in fertility and sexual function in women [7,8].…”

mentioning

confidence: 99%